These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 24726342

  • 1. Assessment of acute bronchodilator effects from specific airway resistance changes in stable COPD patients.
    Santus P, Radovanovic D, Henchi S, Di Marco F, Centanni S, D'Angelo E, Pecchiari M.
    Respir Physiol Neurobiol; 2014 Jun 15; 197():36-45. PubMed ID: 24726342
    [Abstract] [Full Text] [Related]

  • 2. Effect of indacaterol on lung deflation improves cardiac performance in hyperinflated COPD patients: an interventional, randomized, double-blind clinical trial.
    Santus P, Radovanovic D, Di Marco S, Valenti V, Raccanelli R, Blasi F, Centanni S, Bussotti M.
    Int J Chron Obstruct Pulmon Dis; 2015 Jun 15; 10():1917-23. PubMed ID: 26392766
    [Abstract] [Full Text] [Related]

  • 3. Effect of indacaterol on dynamic lung hyperinflation and breathlessness in hyperinflated patients with COPD.
    Beeh KM, Wagner F, Khindri S, Drollmann AF.
    COPD; 2011 Oct 15; 8(5):340-5. PubMed ID: 21793716
    [Abstract] [Full Text] [Related]

  • 4. Bronchodilator Responses in Respiratory Impedance, Hyperinflation and Gas Trapping in COPD.
    Milne S, Hammans C, Watson S, Farah CS, Thamrin C, King GG.
    COPD; 2018 Oct 15; 15(4):341-349. PubMed ID: 29799289
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE, Laveneziana P, Ora J, Webb KA, Lam YM, Ofir D.
    Thorax; 2009 Mar 15; 64(3):216-23. PubMed ID: 19052054
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison.
    Mahler DA, D'Urzo A, Bateman ED, Ozkan SA, White T, Peckitt C, Lassen C, Kramer B, INTRUST-1 and INTRUST-2 study investigators.
    Thorax; 2012 Sep 15; 67(9):781-8. PubMed ID: 22544891
    [Abstract] [Full Text] [Related]

  • 10. Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS use.
    Decramer M, Dahl R, Kornmann O, Korn S, Lawrence D, McBryan D.
    Respir Med; 2013 Feb 15; 107(2):223-32. PubMed ID: 23219347
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD.
    Jones PW, Mahler DA, Gale R, Owen R, Kramer B.
    Respir Med; 2011 Jun 15; 105(6):892-9. PubMed ID: 21397482
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD.
    Guenette JA, Raghavan N, Harris-McAllister V, Preston ME, Webb KA, O'Donnell DE.
    Respir Med; 2011 Dec 15; 105(12):1836-45. PubMed ID: 21917440
    [Abstract] [Full Text] [Related]

  • 15. Effect of an additional dose of indacaterol in COPD patients under regular treatment with indacaterol.
    Cazzola M, Segreti A, Stirpe E, Puxeddu E, Ora J, Rogliani P, Matera MG.
    Respir Med; 2013 Jan 15; 107(1):107-11. PubMed ID: 23083839
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: the ENLIGHTEN study.
    Dahl R, Chapman KR, Rudolf M, Mehta R, Kho P, Alagappan VK, Chen H, Banerji D.
    Respir Med; 2013 Oct 15; 107(10):1558-67. PubMed ID: 23867808
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chronic treatment with indacaterol and airway response to salbutamol in stable COPD.
    Cazzola M, Rogliani P, Ruggeri P, Segreti A, Proietto A, Picciolo S, Matera MG.
    Respir Med; 2013 Jun 15; 107(6):848-53. PubMed ID: 23490225
    [Abstract] [Full Text] [Related]

  • 20. Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD.
    Aliverti A, Rodger K, Dellacà RL, Stevenson N, Lo Mauro A, Pedotti A, Calverley PM.
    Thorax; 2005 Nov 15; 60(11):916-24. PubMed ID: 15994253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.